Cargando…

High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma

BACKGROUND: The protein high-mobility group AT-hook 1 (HMGA1) has been demonstrated that modulated cellular proliferation, invasion, and apoptosis with a poor prognosis in miscellaneous carcinomas. However, the mechanism of circumstantial carcinogenesis and association with the immune microenvironme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yong-Guang, Yang, Cheng-Kun, Wei, Zhong-Liu, Liao, Xi-Wen, He, Yong-Fei, Zhou, Xin, Huang, Hua-Sheng, Lan, Chen-Lu, Han, Chuang-Ye, Peng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765458/ https://www.ncbi.nlm.nih.gov/pubmed/35058711 http://dx.doi.org/10.2147/IJGM.S344858

Ejemplares similares

Metformin alleviates breast cancer through targeting high‐mobility group AT‐hook 2
por: Li, Yang, et al.
Publicado: (2020)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma
por: Xu, Jun Hui, et al.
Publicado: (2021)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
por: Cheng, Sheng, et al.
Publicado: (2023)

The Dimerization State of the Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2)
por: Frost, Lorraine, et al.
Publicado: (2015)

High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia
por: Unachukwu, Uchenna, et al.
Publicado: (2020)

Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma
por: Cui, Juncheng, et al.
Publicado: (2022)

Modulation of Vascular Smooth Muscle Cell Phenotype by High Mobility Group AT-Hook 1
por: Jung, Yoojin, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis
por: Zhang, Qiang-Bo, et al.
Publicado: (2016)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Linjun, et al.
Publicado: (2022)

LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1
por: Cai, Yixuan, et al.
Publicado: (2021)

CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma
por: Su, Qiuming, et al.
Publicado: (2022)

POZ/BTB and AT-Hook-Containing Zinc Finger Protein 1 (PATZ1) Suppresses Progression of Ovarian Cancer and Serves as an Independent Prognosis Factor
por: Zhao, Cuihong, et al.
Publicado: (2018)

TAGLN and High-mobility Group AT-Hook 2 (HMGA2) Complex Regulates TGF-β-induced Colorectal Cancer Metastasis
por: Zhou, Huimin, et al.
Publicado: (2020)

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
por: Wei, Zhong-liu, et al.
Publicado: (2022)

Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma
por: Zhang, Wei, et al.
Publicado: (2020)

High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition
por: Wu, Qing-Qing, et al.
Publicado: (2020)

miR‐541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high‐mobility group AT‐hook 2
por: Xu, Li, et al.
Publicado: (2018)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

High Expression Levels of SLC38A1 Are Correlated with Poor Prognosis and Defective Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Yun, et al.
Publicado: (2021)

Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patients
por: Zhu, Weiwei, et al.
Publicado: (2018)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma
por: Xu, Jun Hui, et al.
Publicado: (2021)

CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2019)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma
por: Che, Yibin, et al.
Publicado: (2022)

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma
por: Zhen, Jing, et al.
Publicado: (2023)

Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma
por: Cai, Jie, et al.
Publicado: (2016)

Corrigendum to “System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma”
por: Xu, Jun Hui, et al.
Publicado: (2022)

Micro RNA‐4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy
por: Zhang, Tian‐Qi, et al.
Publicado: (2018)

Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2021)

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023)

The Hook
por: Krevolin, Richard
Publicado: (2015)

Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis
por: Feng, Yan, et al.
Publicado: (2023)

The Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2): Biochemical and Biophysical Properties, and Its Association with Adipogenesis
por: Su, Linjia, et al.
Publicado: (2020)

The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
por: Ding, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1f83rmir97u7jr2mndgkjlib56